Next Pick BGMD - In at $0.83
BGMD just did a secondary offering at $1.00 ~ It has not closed yet. Most of these things always drop big on announcement of the secondary, then go back up again when the secondary's are finalized. $0.83 is a nice discount off the $1.00 secondary offering price.
USE OF PROCEEDS
We estimate that the net proceeds to us from this offering will be approximately $2.1 million, excluding the proceeds, if any, from the exercise of the warrants, and after deducting the underwriting discounts and commissions and estimated offering expenses payable by us. If the warrants are purchased and fully exercised for cash, we would receive additional proceeds of $1.25 million.
We intend to use the net proceeds of this offering for our support of the U.S. launch of the first automated test for galectin-3, support to our automated partners for the development and commercialization of additional automated tests for galectin-3, our proposed expansion of clinical claims and indications for galectin-3 testing, and other general corporate purposes, including but not limited to, working capital, intellectual property protection, enforcement and in-licensing, capital expenditures and collaborations.
We have not determined the amounts we plan to spend on any of the areas listed above or the timing of these expenditures. As a result, our management will have broad discretion to allocate the net proceeds we receive in connection with securities offered pursuant to this prospectus for any purpose. Pending application of the net proceeds as described above, we may initially invest the net proceeds in short-term, investment-grade, interest-bearing securities or apply them to the reduction of short-term indebtedness.